You have no items in your shopping cart.
Human CD3E [orb2993920]Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 28.5 KDa. Observed: 32-40 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg- Cynomolgus CD3E [orb2994067]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 38 KDa. Observed: 38-55 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Cynomolgus CD3d [orb2994176]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 10.4 KDa. Observed: 20-35 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human CD3E [orb2994304]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 38.7 KDa. Observed: 40-50 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Cynomolgus CD3d [orb2994733]
Unconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 36.7 KDa. Observed: 50-65 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human CD3E [orb2994985]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 12.79 KDa. Observed: 15-21 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human CD3D [orb2994986]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 10.59 KDa. Observed: 18-30 KDa, reducing conditions
50 μg, 500 μg, 1 mg, 10 μg - Human CD3D&CD3E Heterodimer V2 [orb2992888]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 14.6&16.0 KDa. Observed: 20&(22-38) KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human CD3D&CD3E Heterodimer [orb2993825]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 37&39.2 KDa. Observed: 40-60 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Biotinylated Human CD3E [orb2993856]
Biotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 40.5 KDa. Observed: 45-60 KDa, reducing conditions
100 μg, 20 μg